Recordati Rare Diseases showcased significant findings on Castleman Disease at the ASH Annual Meeting, focusing on AI innovations, morbidity data, and pediatric implications.

At the upcoming ASH annual meeting, Recordati Rare Diseases will showcase nine posters detailing groundbreaking research in rare hematologic disorders, focusing on Castleman disease and cold agglutinin disease.

Researchers at Okayama University have identified essential molecules related to the pathology of Idiopathic Multicentric Castleman Disease, marking a significant step towards a potential cure.